Guidance Document for Industry - Review of Drug Brand Names

To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.

Données et ressources

Info additionnelle

Champ Valeur
Source
Version
Producteur
Courriel de l'auteur
Mainteneur
Courriel du mainteneur
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Ligne directrice à intention de l'industrie - Examen des marques nominatives de médicament
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Langue
Contact Person
Contact Email
Dictionnaire de données
Open Canada Date Published 2014-10-22 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["Document d'orientation pour l'industrie", "examen des noms de marque de médicaments", "autorisation de mise en marché", "nom proposé trompeur", "confondu avec un autre produit", "autorisé pour utilisation", "prévention des erreurs de médication"], "en": ["Guidance document for industry", "review of drug brand names", "market authorization", "a proposed name to be misleading", "confused with another product", "authorized for use", "preventing medication errors"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source